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Introduction
Gestational choriocarcinoma (GCC) is the most malignant of the four 
gestational trophoblastic diseases. The others are: invasive mole, placental site 
trophoblastic tumour, and epithelioid trophoblastic tumour.[1,2,3,4,5,6] We report 
five cases of GCC managed at the Juba Medical Complex and Juba Teaching 
Hospital since 2011. The purpose is to draw attention to this condition with 
its complex presentations, need for early diagnosis and potential for cure. 
Recurrent vaginal bleeding in the presence of a pregnancy of unknown location 
and a positive pregnancy test should make the clinician suspect GCC. A woman 
of childbearing age with disseminated malignancy of unknown primary cause 
should have a pregnancy test.[1,2,3,6]
Case 1
A 28-year-old lactating woman (para 3+0) presented on 11/12/2011 with heavy 
vaginal bleeding. She was restless, sweaty, with cold extremities and severe 
pallor. Her temperature was 36.5 C, pulse 120/min and BP 80/50mm Hg, 
A pelvic examination revealed vaginal blood clots and products of conception 
plugged in the cervix. The uterus was equivalent to 10-12 weeks gestation, 
freely mobile with no adnexal masses.
After a diagnosis of an incomplete miscarriage, placenta-like tissue was evacuated 
from the uterus and sent for histology. Hb was2.8 g/dl and the patient transfused 
with two units of blood.
She delivered a full-term male baby at home 8/8/2011. She had continued 
bleeding for the subsequent two months. She had had an ultrasound scan (USS) 
and an evacuation was done for retained placental tissue. She was discharged on 
haematinics with a diagnosis of retained piece of placenta.
However, bleeding continued and admitted again on 22/12/2011 with vaginal 
bleeding and collapse: pulse of 130 min. BP 60 /40 mmHg, and the vagina 
full of clots. Cervix 
was closed, bulky 
uterus, no adnexal 
masses. A gestational 
trophoblastic neoplasia 
was suspected. A 
urinary pregnancy test 
was strongly positive.
Her Hb was 2.5 g/dl, 
so she was transfused 
with two units of 
blood.  Her  chest 
Xray was normal (see 
Figure 1). USS showed 
normal abdominal 
organs. Histology 
of the vaginal 
products confirmed 
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Figure 1. Case 1 chest x-ray (Credit: Kizza Paul and Paula 
Nuer)
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a choriocarcinoma. She was graded as a low risk 
choriocarcinoma and for low risk chemotherapy.
After two cycles of chemotherapy the urine pregnancy 
test was negative. After the 4th cycle she absconded but 
returned six weeks later due to vaginal bleeding. The 
pregnancy test was positive. High risk chemotherapy was 
started. She completed six cycles on 5/10/2012.  βhCG 
was normal. Two months later, she had miscarriage at six 
weeks pregnancy. βhCG was normal two weeks later.
Case 2
A 22-year old woman (para 3+1) presented on 4/7/2012 
with recurrent vaginal bleeding following miscarriage of 
an abnormal pregnancy ten months earlier. Pulse was 86/
min, BP 120/70 mm Hg. The uterus size was equal to a 
12 weeks pregnancy. A pelvic examination was normal.
Hb was 9.1 g/dl, pregnancy test was positive, chest X-ray 
was normal, (see Figure 2); USS showed a distorted 
heterogeneous mass 12x1.6x6 cm in the endometrium 
partially attached to the uterus. Curettage produced 
necrotic tissue.  A missed abortion was considered the 
most likely diagnosis. She was discharged the following 
day with a plan for histology to be checked in three weeks. 
Three weeks later, she was readmitted with heavy vaginal 
bleeding.  A pregnancy test was strongly positive. Low risk 
choriocarcinoma was suspected clinically and confirmed 
histologically. The chemotherapy was started immediately. 
After four cycles of chemotherapy the urine pregnancy 
test was negative and βhCG remained low.
Seven months later, an USS showed a 12-week old foetus 
and she delivered a normal 3.2kg baby at term. 
Case 3
A 28-year-old woman (para 6+1), presented with recurrent 
vaginal bleeding following spontaneous vaginal delivery in 
October 2012. She had had three evacuations of retained 
products of conception. The vaginal bleeding persisted 
with abdominal pain but no cough or haemoptysis.
Examination revealed severe pallor, Hb of 5.5 g/with 
pulse 98/min, BP 90/60 mm Hg. The size of the uterus 
was equivalent to a 12–14-weeks pregnancy. Pelvic 
examination was normal apart from blood oozing from 
the cervical os and a chest X-ray showed cannon ball 
metastases (Figure 3).
An USS showed normal ovaries and an intrauterine 
heterogeneous mass with no clear demarcation between 
the mass and myometrial wall. βhCG was 31,537mlu/ml. 
High-risk choriocarcinoma was diagnosed and the patient 
was started on high-risk chemotherapy.  After the 9th 
cycle, the lung masses had markedly shrunk (Figure 4) 
and βhCG was normal
Case 4
A 42-year old woman (para 7+0), having had her last 
delivery five years previously, presented on 15/06/2012 
with recurrent vaginal bleeding and haemoptysis. On 
Figure 2. Case 2. Normal chest X-ray Figure 3. Case 3. X-ray showing three cannon ball masses 
balls in lungs (Credit: Kizza Paul and Paula Nuer)
Figure 4. Case 3. X-ray with remaining coin like lesion 
(Credit: Kizza Paul and Paula Nuer) 
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examination she was very pale with a blood pressure of 
110/70 mmHg and a clear chest on auscultation. Pelvic 
examination revealed dark blood from the cervical os 
and a uniformly enlarged uterus consistent with a  12 – 
14 weeks pregnancy. Her Hb was 5.0g/dl and she was 
transfused with three units of blood.
An USS showed in intrauterine mass with associated fluid. 
A dilation and curettage produced necrotic tissue and 
histology confirmed a choriocarcinoma.
A chest X-ray showed lung deposits (Figure 5). Due to 
her age, bleeding, and difficulty in obtaining drugs and 
blood, she underwent a hysterectomy. Subsequently, 
high-risk chemotherapy was given and after two cycles 
the urine pregnancy test was negative. She completed five 
cycles and the βhCG remained normal.
Case 5
A 26-year old woman (para 5 + 0) was referred with 
persistent vaginal bleeding and a diagnosis of metastatic 
endometrial carcinoma. Her background included 
previous normal deliveries and excision of a vaginal 
tumour at another hospital.
On examination she was pale (Hb 3.5 g/dl). There was a 
bleeding vaginal ulcer and uterus size was consistent with 
a 14-weeks pregnancy. Bilateral adnexal masses were felt.
An USS showed a mass in the endometrial cavity and 
bilateral adnexal cystic masses with normal liver and spleen. 
A pregnancy test was positive. She was transfused with five 
units of blood and a hysterectomy was performed. 
Her recovery was complicated by a bleeding vaginal ulcer 
and severe wound sepsis. Due to financial constraints, 
high risk chemotherapy could not be procured. Low risk 
chemotherapy was started to control the bleeding. At 
the end of first cycle, bleeding and sepsis were clearing. 
Histology confirmed choriocarcinoma and the patient 
received two further units of blood
After the 5th cycle of chemotherapy the βhCG was 
normal. She requested to visit her children over Christmas 
and return after a week. She returned four months later 
with right hemiplegia and a high βhCG. A Chest X-ray 
revealed a coin lesion in the right lower lung zone (Figure 
6.). A brain metastasis was considered the most likely 
cause of the hemiplegia. She died before medication could 
be obtained.
The operative specimens are shown in Figures 7 and 8. 
The endometrium was hypertrophied with a friable cavity 
mass, the cervix distorted and the ovaries were polycystic.
Histologically the tumour consisted of sheets of 
markedly pleomorphic malignant trophoblastic cells 
with prominent macro-nucleoli and prominent mitotic 
activity. There was myometrial invasion and numerous 
foci of necrosis. 
Figure 5. Case 4. X-ray showing TB like deposits in lungs in 
patient with haemoptysis after hysterectomy (Credit: Kizza 
Paul and Paula Nuer)
Figure 6. Case 5. X-ray. Coin like lesion in right lung (Credit: 
Kizza Paul and Paula Nuer) 
Figure 7. Case 5. Hysterectomy specimen with GCC and 
cystic ovaries (Credit: Changkel Banak)
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Discussion
Five patients with GCC are reported. Four of these 
patients are in remission, two resumed their fertility 
and one delivered a normal female baby, another had a 
miscarriage and their βhCG are normal. This pattern has 
been reported elsewhere. [2.3,6] The fifth died from probable 
brain metastases leading to her hemiplegia.[7]
GCC is a malignant tumour arising from the placenta. 
Histologically it shows sheets of anaplastic cytotrophoblast 
cells, vascular necrosis and vascular invasion but chorionic 
villi are absent. When in the uterus, it invades the 
endometrium then myometrium which may perforate. 
Metastasis occurs early and in most cases GCC is a systemic 
disease.[1,2,3,6] GCC is highly sensitive to chemotherapy; 
urinary or serum βhCG is a useful monitoring tool.[4,5,7] 
Untreated GCC mortality is 100%, but with current 
chemotherapy, over 98% of patients achieve remission 
even without surgery.[1,2,3,7,8]
Sometimes the history of a molar pregnancy may be 
obscured by subsequent pregnancies. In a 1995 study by 
Fisher et al., the genetic origin of GCC that developed 
after a full-term normal twin pregnancy was traced to a 
molar pregnancy that occurred four years before.[1, 2, 6, 10]
GCC is most common in young women.  Our patients’ 
ages ranged from 22 to 42 years (mean 29.5 years). Others 
have reported similarly.[11,12] Early diagnosis is crucial in 
obtaining the best outcome.[1,2,3,6,8,9] A report from the 
Netherlands showed a post-term GCC had a median 
diagnosis interval of 16 weeks. The author ascribes 68% 
and 28% lung and liver metastases respectively in his 
patients were due to delayed diagnosis. He recommends 
that post term GCC be treated as a high-risk disease.[8]
Three of our patients had GCC following normal 
pregnancies, the time interval to diagnosis ranging 
from four months to five years and all needed high risk 
treatment.
Intra-placental GCC develops in a placenta of normal 
baby; 30 cases have been reported and in 17 diagnosis in 
the baby lead to the diagnosis of GCC in the mother.[2,8]
The common way in which GCC presents is with bleeding 
from the uterus or vaginal metastases. A temptation to 
biopsy bleeding vaginal lesion must be avoided until the 
pregnancy test is negative. The bleeding vaginal ulcer may 
be a GCC metastasis which is highly vascular and biopsy 
will lead to bleeding as happened in case 5.
Most GCC follow molar pregnancy and repeated 
evacuations for a molar may increase the patient’s chances 
of developing GCC. A second evacuation may be done in 
selected cases and when βhCG is less 5000IU/L. βhCG 
should be normal within six months in most cases.[2,4,6,7,15]
Haemoptysis, chest pain and dyspnoea due to lung 
metastases are other presenting or complicating features. 
Haemoperitoneum due to bleeding liver metastases or 
abdominal masses and intestinal obstruction have also 
been reported.[1,2,6]
A third of GCC patients have no pelvic symptoms and 
may present with headache, seizures, or hemiplegia due to 
brain metastases.[2,6]
Investigations to be considered depending on availability 
are:
• Urine pregnancy test
• USS to show masses in the uterus, liver and spleen 
and rule out pregnancy.
• Serum βhCG.
• Chest X-ray to look for metastases.
• Biopsy and uterine curettage may lead to severe 
haemorrhage and uterine perforation. It is not 
mandatory to have histology for the diagnosis of 
GCC.[1,2,5,6]
• CT scan to seek metastases in the liver and especially 
the brain. 
The mainstay of GCC treatment is chemotherapy. It is 
essential that treatment is undertaken by trained staff that 
follows clear protocol, so enhancing patient safety. It has 
been shown that mortality of this condition is lower if 
managed by those who are experienced in handling it.[13, 
14] We used Charing Cross Hospital London protocol for 
GCC chemotherapy.[1,2,6] Brain metastases used to carry 
poor prognosis. Currently high dose chemotherapy with 
intrathecal drugs for a patient who has not been previously 
on chemotherapy carried a good prognosis. 
Patients are graded into low risk, high risk and ultra-high 
risk.[1,2,3,6] Low risk may be treated with a single drug while 
high risk needs multiple drugs. These drugs are toxic and 
Figure 8. Case 5. Opened specimen showing GCC in 
endometrial cavity (Credit Changkel Banak)
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if not used properly can be fatal to the patient.
In our environment where blood is hard to obtain, uterine 
bleeding in a patient of 40 years and above, a hysterectomy 
may be appropriate. Surgery may be definitive treatment 
and reduces the duration of chemotherapy.[5,8,13,14,15] It 
must be remembered that GCC is a systemic disease and 
so most patients need chemotherapy after surgery.
Role of surgery
Surgery may be used in the following:
• Resecting localised disease that is resistant to 
chemotherapy e.g. lung, liver, intestinal or brain 
metastases.
• Reduce tumour mass like a uterus riddled with 
tumour or a patient who has completed her family.
• Ovaries are usually cystic due to βhCG they must be 
preserved as these are young women and need their 
ovarian function.  
• Patient with uncontrollable haemorrhage from the 
uterus or liver, etc.
• A wedge resection of a chemotherapy resistant 
localised tumour in myometrium for a patient 
desiring to keep her fertility.
Follow up of these patients may lead to early detection of 
neoplastic changes and hence good treatment results.  
Recommendations
• Set up a treatment protocol for gestational 
choriocarcinoma in South Sudan.
• Follow up all post-molar pregnancies in treating 
facilities.
• Explore means of obtaining drugs to expand the 
availability of treatment more widely. 
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